Clinical Trial

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

Study acronym: STATIC
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess whether withdrawal of aminosalicylate (5-ASA) is non-inferior to continuation of 5-ASA therapy in Crohn's disease (CD) subjects in remission.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2017-08-23; most recent amendment 2026-05-26.
Status change: Recruiting → Active, Not Recruiting 2024-05-07
Status change: Not Yet Recruiting → Recruiting 2018-02-12
Trial Details
NCT Number NCT03261206
Lead Sponsor Alimentiv Inc.
Collaborators: Academic Medical Organization of Southwestern Ontario
Conditions Crohn Disease, Remission
Enrollment 334 participants
Start Date 2017-11-20
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-28